The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor.
Open accessAbstract
Decorin, a small leucine-rich proteoglycan, is capable of suppressing the growth of various tumor cell lines when expressed ectopically. In this report, we investigated the biochemical mechanism by which decorin inhibits cell cycle progression. In A431 squamous carcinoma cells, decorin proteoglycan or protein core induced a marked growth suppression, when either exogenously added or endogenously produced by a transgene. Decorin caused rapid phosphorylation of the EGF receptor and a concurrent activation of mitogen-activated protein (MAP) kinase signal pathway. This led to a protracted induction of endogenous p21, a potent inhibitor of cyclin-dependent kinases, and ultimate cell cycle arrest. Biglycan, a related proteoglycan, had no effect. Moreover, decorin activated the EGF receptor/MAP kinase/ p21 axis in cell lines of various histogenetic backgrounds. These results provide the first evidence that EGF and decorin converge functionally to regulate the cell cycle through activation of a common pathway which ultimately leads to growth suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Self-citationRole of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Growth factor signaling by receptor tyrosine kinases
Schlessinger, J., & Ullrich, A. (1992) · Neuron · doi:10.1016/0896-6273(92)90177-f · Cited by 1,430
Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility
Danielson, K. G., Baribault, H., Holmes, D. F., Graham, H., Kadler, K. E., & Iozzo, R. V. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.3.729 · Cited by 1,406
Self-citationNew functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E. (1992) · Nature · doi:10.1038/360361a0 · Cited by 974
Datto, M. B., Li, Y., Panus, J. F., Howe, D. J., Xiong, Y., & Wang, X. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5545 · Cited by 950
Vogel, K. G., Paulsson, M., & Heinegård, D. (1984) · Biochemical Journal · doi:10.1042/bj2230587 · Cited by 856
Induction of WAF1/CIP1 by a p53-independent pathway.
Michieli, P., Chedid, M., Lin, D. P., Pierce, J. H., Mercer, W. E., & Givol, D. (1994) · PubMed · Cited by 768
Fisher, L. W., Termine, J. D., & Young, M. F. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83781-4 · Cited by 702
Chin, Y. E., Kitagawa, M., Su, W.-C. S., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 696
Iozzo, R. V., & Murdoch, A. D. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621059 · Cited by 642
Self-citationPrimary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA.
Krusius, T., & Ruoslahti, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7683 · Cited by 533
Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts, J. M., & Ross, R. (1996) · Cell · doi:10.1016/s0092-8674(00)81801-2 · Cited by 515
Iozzo, R. V. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709108551 · Cited by 498
Self-citationGene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A., & Border, W. A. (1996) · Nature Medicine · doi:10.1038/nm0496-418 · Cited by 482
Anchorage-dependent Cell Cycle Progression
Assoian, R. K. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.1 · Cited by 377
Model Structure of Decorin and Implications for Collagen Fibrillogenesis
Weber, I. T., Harrison, R. W., & Iozzo, R. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31767 · Cited by 354
Self-citationBarnes, D. W. (1982) · The Journal of cell biology · doi:10.1083/jcb.93.1.1 · Cited by 277
De Luca, A., Santra, M., Baldi, A., Giordano, A., & Iozzo, R. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18961 · Cited by 229
Self-citationDe novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells.
Santra, M., Skorski, T., Calabretta, B., Lattime, E. C., & Iozzo, R. V. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7016 · Cited by 210
Self-citationTransformational and altered signal transduction by a naturally occurring mutant EGF receptor.
Moscatello, D. K., Montgomery, B., Sundareshan, P., McDanel, H. J., Wong, M. Y., & Wong, A. J. (1996) · PubMed · Cited by 207
Self-citationSantra, M., Mann, D. M., Mercer, E. W., Skorski, T., Calabretta, B., & Iozzo, R. V. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119507 · Cited by 196
Self-citationRegulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway.
Liu, Y., Martindale, J. L., Gorospe, M., & Holbrook, N. J. (1996) · PubMed · Cited by 192
The effect of chondroitin sulphate–protein on the formation of collagen fibrils in vitro
Toole, B. P., & Lowther, D. A. (1968) · Biochemical Journal · doi:10.1042/bj1090857 · Cited by 181
Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone
Day, A. A., McQuillan, C. I., Termine, J. D., & Young, M. R. (1987) · Biochemical Journal · doi:10.1042/bj2480801 · Cited by 152
Ádány, R., Heimer, R., Caterson, B., Sorrell, J. M., & Iozzo, R. V. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38605-3 · Cited by 145
Self-citationFan, Z., Lu, Y., Wu, X., DeBlasio, A., Koff, A., & Mendelsohn, J. M. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.1.235 · Cited by 129
A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis
Elledge, S. J., Winston, J. T., & Harper, J. W. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)10030-1 · Cited by 120
Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis.
Mann, D. M., Yamaguchi, Y., Bourdon, M. A., & Ruoslahti, E. I. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34123-7 · Cited by 102
Self-citationRecombinant Decorin Glycoforms
Ramamurthy, P., Hocking, A. M., & McQuillan, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19578 · Cited by 101
Self-citationDefize, L. H. K., Moolenaar, W. H., van der Saag, P. T., & de Laat, S. W. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04345.x · Cited by 71
Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase
Mohammadi, M., Honegger, A., Sorokin, A., Ullrich, A., Schlessinger, J., & Hurwitz, D. R. (1993) · Biochemistry · doi:10.1021/bi00085a004 · Cited by 54
(1995) · PubMed
Cited by
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
Self-citationProteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
Self-citationProteoglycans in cancer biology, tumour microenvironment and angiogenesis
Iozzo, R. V., & Sanderson, R. D. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01236.x · Cited by 569
Self-citationBiological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction
Schaefer, L., & Iozzo, R. V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800020200 · Cited by 549
Self-citation
Metadata
- Authors
- Moscatello, D. K., Santra, M., Mann, D. M., McQuillan, D. J., Wong, A. J., & Iozzo, R. V.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-01-15
- Volume
- 101
- Issue
- 2
- Pages
- 406-412
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2023104790
- Cited by
- 272
- References
- 42
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.